Healthcare International Partners

What Healthcare International Partners does

Healthcare International Partners (HIP) is a privately held Florida LLC founded in 2009 that provides integrated regulatory and commercialization services to medical device, pharmaceutical, and broader healthcare product manufacturers seeking to enter Latin American, Caribbean, and select US markets. The firm's core offerings span regulatory strategy and roadmap development, dossier preparation and submission, regulatory compliance monitoring, liaison and representation with national health authorities, pharmacovigilance and medical device vigilance reporting, facility registration, trademark protection, and Emergency Use Authorization support across categories including pharmaceuticals, medical devices, veterinary medicines, pesticides, agrochemicals, food, dietary supplements, cosmetics, and complementary medicines.

HIP operates through direct offices in five countries (United States/Miramar FL, Mexico City, Barranquilla, Buenos Aires, and Istanbul) and an affiliate network covering twelve additional markets spanning Ecuador, Peru, Puerto Rico, Chile, Saudi Arabia, the Dominican Republic, and seven Central American countries — enabling local in-country regulatory representation across a 17-country footprint. The firm is led by CEO Margarita Morales-Perez and runs an enterprise field-sales motion targeting market-leading manufacturers. Pricing is not publicly disclosed and operates as bespoke professional services engagements. The company has no disclosed funding rounds, no M&A history, and no public financial filings, indicating a self-funded, owner-operated consultancy model.

Name

Healthcare International Partners

Legal name

Healthcare International Partners, LLC

Website

https://hip-llc.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Healthcare International Partners is a Florida-based regulatory and commercialization consultancy founded in 2009 that helps medical device, pharmaceutical, and healthcare product manufacturers enter Latin American, Caribbean, and select US markets via direct offices and an affiliate network across 17 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Miramar Beach

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Regulatory Services: HIP provides comprehensive regulatory services including strategy development, dossier preparation, compliance monitoring, and regulatory agency liaison. The company serves as a value-enhancement partner to medical device and healthcare companies, enabling them to commercialize products across Latin America, the Caribbean, and select US markets.

Go-to-market motion1 record

Distribution channels1 record

Core offering

HIP is a value-enhancement partner providing integrated regulatory and commercialization services to medical device, pharmaceutical, and healthcare product manufacturers seeking to enter Latin America, the Caribbean, and select US markets. Services span regulatory strategy and roadmap development, dossier preparation and submission, liaison and representation with regulatory agencies, pharmacovigilance and medical device vigilance reporting, trademark protection, facility registration, and Emergency Use Authorization support, delivered through a network of five direct offices and twelve regional affiliates.

Product overview

Healthcare International Partners (HIP) is a value-enhancement partner providing integrated regulatory and commercialization services to medical device, pharmaceutical, and healthcare product companies. The company operates as a services-based organization rather than a software product company, offering a comprehensive suite of regulatory strategy, compliance, vigilance reporting, trademark protection, and market commercialization services. HIP's services span regulatory strategy and roadmap development, dossier preparation and submission, liaison with regulatory agencies, hosting on behalf of manufacturers, pharmacovigilance and adverse event reporting, medical device vigilance reporting, facility registration, trademark protection, and emergency use authorization support across Latin America, the Caribbean, and select US markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Strategy Services Comprehensive regulatory strategy and roadmap development to help clients comply with government regulations protecting public health across pharmaceuticals, medical devices, veterinary medicines, pesticides, food, and cosmetics sectors.
• Regulatory Compliance Services Dossier preparation and submission, regulatory compliance monitoring, liaison with regulatory agencies, and representation services to ensure products meet all market-specific regulatory requirements.
• Medical Device Vigilance Services Adverse event (AE) reporting and technovigilance reporting services including Medical Device Vigilance Reporting and Pharmacovigilance and AE Reporting to regulatory agencies.
• Commercialization Services Strategic commercialization services enabling medical companies to enter Latin America, the Caribbean, and select US markets through entrepreneurial and cost-effective approaches.
• Trademark Protection Services Intellectual property protection services including trademark registration and protection across multiple jurisdictions.
• Facility Registration Services Registration and listing of facilities and establishments with regulatory agencies across target markets.
• Emergency Use Authorization Services Support for Emergency Use Authorization (EUA) applications and processes for products in different countries with similar regulatory pathways.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered minor.

• Cuenca Ecuador AffiliateminorOthersAffiliate relationship in Cuenca, Ecuador providing local regulatory support and market access services in the Ecuadorian market.
• Lima Peru AffiliateminorOthersAffiliate relationship in Lima, Peru offering regulatory services and commercialization support for the Peruvian healthcare market.
• San Juan Puerto Rico AffiliateminorOthersAffiliate partnership in San Juan, Puerto Rico extending HIP's regulatory services to this US territory market.
• Santiago Chile AffiliateminorOthersAffiliate partnership in Santiago, Chile providing regulatory and market access services for the Chilean healthcare sector.
• Saudi Arabia AffiliateminorOthersAffiliate relationship covering Saudi Arabia, extending HIP's reach into the Middle Eastern market for healthcare regulatory services.
• Dominican Republic AffiliateminorOthersAffiliate partnership in Dominican Republic providing regulatory support for market entry in the Caribbean region.
• Central America Affiliate NetworkminorOthersAffiliate network covering El Salvador, Belize, Costa Rica, Guatemala, Honduras, Nicaragua, and Panama providing comprehensive Central American market coverage.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO with dedicated regulatory and pharmacovigilance services for medical device and pharmaceutical sponsors. Comparable to HIP on regulatory advisory scope, though with a stronger clinical research emphasis.
• PharmaLex (Cencora): Regulatory affairs, pharmacovigilance, and quality management consultancy now part of Cencora (formerly AmerisourceBergen). Comparable to HIP's dossier preparation, regulatory strategy, and vigilance services for medical product manufacturers.
• Integrium: Clinical research and regulatory services firm with explicit Latin America focus. Directly comparable to HIP's regional LATAM/Caribbean positioning for medical device and pharmaceutical regulatory support.
• Voisin Consulting Life Sciences: European-headquartered regulatory affairs, clinical, and quality consulting firm serving medical device and pharma clients. Comparable to HIP as a specialist regulatory consultancy targeting healthcare product manufacturers across multiple geographies.
• ProPharma Group: Global regulatory, compliance, and quality consulting firm serving pharmaceutical, medical device, and biotech manufacturers. Closely comparable to HIP as a specialist regulatory advisory serving healthcare product companies across multiple jurisdictions.

Broad incumbents

• ICON plc: Global CRO and consulting firm offering regulatory affairs, pharmacovigilance, and medical device services. Comparable in regulatory service line but vastly larger and broader geographically than HIP.
• Charles River Laboratories: Major preclinical and clinical services provider with regulatory and safety consulting capabilities. Overlaps with HIP on medical device and pharma regulatory services as part of a much wider life sciences services portfolio.
• Parexel International: Large global CRO with extensive regulatory affairs, pharmacovigilance, and market access services. Overlaps with HIP's full suite of regulatory offerings but serves clients across many more geographies and therapeutic areas.
• IQVIA: World's largest CRO with integrated regulatory, safety, and commercialization services. Competes with HIP on regulatory filings and pharmacovigilance but at significantly broader scale and across a wider product portfolio.

Emerging players

• Clinipace Worldwide (dMed Global): Clinical research and regulatory services organization with strong Asia and emerging market presence. Comparable to HIP as an emerging-market focused regulatory/clinical services provider, though its geographic concentration differs from HIP's LATAM focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/hiphealthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthcare International Partners